SCHEMBL6629307

SCHEMBL6629307

CN1c2ccc(N3C(=O)CCC3=O)cc2C(C)(C)C12C=Cc1cc(Br)ccc1O2

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.48
KMT2A Q03164 3/20 0.48
GFER P55789 1/20 0.48
NPSR1 Q6W5P4 3/20 0.48
GAA P10253 3/20 0.48
MAPT P10636 3/20 0.48
LMNA P02545 2/20 0.48
RECQL P46063 2/20 0.48
TDP1 Q9NUW8 2/20 0.48
ALPG P10696 1/20 0.48
TP53 P04637 1/20 0.48
ALOX15 P16050 1/20 0.48
HSD17B10 Q99714 1/20 0.48
PLIN1 O60240 1/20 0.35
THRB P10828 1/20 0.35
PKM P14618 1/20 0.35
TSHR P16473 1/20 0.35
PLIN5 Q00G26 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
ABHD5 Q8WTS1 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6628794 0.89 MEN1 (0.49) MEN1KMT2AGFERNPSR1GAA
SCHEMBL6632591 0.88 MAPT (0.64) MEN1KMT2AGFERNPSR1GAA
SCHEMBL6629971 0.88 KMT2A (0.48) MEN1KMT2AGFERNPSR1GAA
SCHEMBL6628970 0.87 MEN1 (0.64) MEN1KMT2AGFERNPSR1GAA
SCHEMBL6630951 0.87 MAPT (0.50) MEN1KMT2AGFERNPSR1GAA
SCHEMBL6630260 0.87 MEN1 (0.47) MEN1KMT2AGFERNPSR1GAA
SCHEMBL6627669 0.85 MEN1 (0.38) MEN1KMT2AGFERNPSR1GAA
SCHEMBL6630398 0.83 MEN1 (0.45) MEN1KMT2AGFERNPSR1GAA
SCHEMBL6628087 0.82 MEN1 (0.36) MEN1KMT2AGFERNPSR1GAA
SCHEMBL6628826 0.81 MAPT (0.42) MEN1KMT2AGFERNPSR1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1299391-B1 INDOLINOSPIROPYRAN COMPOUNDS AND METHODS FOR THEIR MANUFACTURE JOHNSON & JOHNSON VISION CARE (US) 2004-12-29 EP disclosed
US-6803471-B2 USEFUL AS PHOTOCHROMIC COMPOUNDS; COVALENTLY ATTACHED TO WANG RESINS AND METHOD OF ATTACHING; OPHTHALMIC LENSES JOHNSON & JOHNSON VISION CARE, INC. 2004-10-12 US disclosed
US-6521753-B1 Indolinospiropyran compounds and methods for their manufacture JOHNSON & JOHNSON VISION CARE, INC. 2003-02-18 US disclosed
US-20020087010-A1 Indolinospiropyran compounds and methods for their manufacture ESSILOR INTERNATIONAL (COMPAGNIE GENERALE D'OPTIQUE) (FR) 2002-07-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020087010-A1 Indolinospiropyran compounds and methods for their manufacture DHPS, IDO1, INMT MEN1 3140/4885KMT2A 2464/4885GFER 1614/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.